Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
12/2010
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/01/2010EP2254872A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/2010
11/30/2010US7842729 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010US20100298302 Novel protein kinase modulators
11/25/2010US20100298301 Oxazole tyrosine kinase inhibitors
11/25/2010US20100298300 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
11/25/2010US20100297034 Osmolyte-containing preparation for use in case of dry mucous membranes
11/24/2010EP2252598A2 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/24/2010CN101891692A Preparation method of homopiperazine
11/18/2010US20100292222 Chemical compounds 751
11/18/2010US20100292221 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/18/2010US20100292220 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/17/2010EP2250157A1 Novel heterocyclic compounds
11/16/2010US7834000 CGRP receptor antagonists
11/11/2010US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof
11/10/2010CN101033232B Method of preparing olanzapine crystal system I
11/09/2010US7829713 Therapeutic piperazines
11/04/2010WO2010125136A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010WO2010125135A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280014 N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010US20100280010 Chemical compounds
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279996 Novel analgesic that binds filamin a
11/04/2010CA2759494A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/04/2010CA2759491A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
11/03/2010EP2029556B1 Salts and crystal modifications thereof
11/03/2010CN101878204A Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/2010
10/28/2010WO2010123956A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273782 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/28/2010US20100273781 Cxcr3 receptor antagonists
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273725 Novel compounds useful in therapeutic and cosmetic methods
10/28/2010CA2758985A1 2,5-disubstituted arylsulfonamide ccr3 antagonists
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121164A2 1,4-benzodiazepinone compounds and their use in treating cancer
10/21/2010US20100267699 Chemical compounds - 643
10/21/2010US20100266711 Thienobenzodiazepine modulators of d1 receptor, d2 receptor, and/or 5-ht2 receptor
10/20/2010EP1317431B1 Polyarylcarboxamides useful as lipid lowering agents
10/20/2010CN101863846A Cis fluorine-containing 1,4-benzodiazepine*derivative and preparation method thereof
10/19/2010US7816398 Fatty alcohol drug conjugates
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/07/2010WO2010113458A1 Method for manufacturing benzodiazepine derivative
10/07/2010US20100256358 Process for Preparing 4-Acetyl-2,3,4,5-tetrahydro-benzo[1,4]diazepine and the Intermediates Thereof
10/07/2010US20100256123 P2x4 receptor antagonist
10/07/2010US20100256120 Amide derivatives
10/07/2010CA2757208A1 Method for manufacturing 1,5-benzodiazepine derivative
09/2010
09/30/2010US20100249115 Substituted heterocyclic compounds
09/30/2010US20100249114 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
09/29/2010EP2231623A1 5-phenyl-lh-benz0 [e] [1, 4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
09/29/2010CN101848899A N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase
09/23/2010CA2755253A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/21/2010CA2440559C Novel non-imidazole compounds
09/16/2010WO2010102513A1 Homopiperazine acethydrazide derivatives, preparation method and uses thereof
09/16/2010US20100234590 Process for the purification ne of olanzapine
09/16/2010US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
09/16/2010US20100234361 Selected cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/09/2010US20100228024 Seven-membered heterocyclic carbenes and their metal complexes
09/09/2010US20100228023 ONE STEP PROCESS FOR THE PREPARATION OF SUBSTITUTED 5, 10-DIHYDRODIBENZO [b,e][1, 4]DIAZEPINE-11-ONES
09/09/2010US20100226969 Compounds for inhibiting protein aggregation, and methods for making and using them
09/08/2010EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/08/2010CN101372477B Method for synthesizing diaza-onium salt
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790709 Heterocyclic compounds, methods of making them and their use in therapy
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010US20100222330 New Compounds
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/01/2010CN101821245A New compounds
08/2010
08/31/2010US7786106 such as 3-[(4-methoxybenzoyl)-amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}phenyl beta -D-glucopyranoside, used as an activated blood coagulation factor X inhibitor; anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism
08/26/2010WO2010095766A1 1,4-benzodiazepin-2-on derivatives
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010CA2752739A1 1,4-benzodiazepin-2-on derivatives
08/25/2010CN101815704A Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
08/24/2010US7781427 cyclization of a 1,4-benzodiazepine with cyclopentene. in a diels-alders reaction to give a decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline, then resolving to form diastereomeric salts and dimer impurities; neuroleptic and dietetic agents
08/19/2010US20100210630 Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/18/2010EP2217576A2 Benzodiazepinone compounds useful in the treatment of skin conditions
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/17/2010US7777031 Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
08/17/2010US7776867 Furanopyrimidines
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/12/2010WO2010090300A1 Diazepinedione derivatives
08/12/2010US20100204468 Process for producing farnesylated dibenzodiazepinone by fermentation
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/11/2010EP2215055A1 New non-peptide derivatives as bradykinin b1 antagonists
08/11/2010EP2214676A1 Substituted diazepan orexin receptor antagonists
08/11/2010CN101801952A N-heterocyclic biaryl carboxamides as ccr receptor antagonists
08/10/2010US7772432 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 60